Pande Atul's Form 4 filing
Immunovant, Inc. (IMVT) · filed Dec 5, 2023
- Accession no.
- 0001764013-23-000155
- Filed
- Dec 5, 2023
- Trade date
- Dec 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $490.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pande AtulCIK 0001643071 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Common Stock | SSaleDisposed | −4,129 | $38.80 | −$160,205.2 | 91,379 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −3,374 | $39.82 | −$134,352.68 | 88,005 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −4,847 | $40.46 | −$196,109.62 | 83,158 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.